BCL2 and B-cell chronic lymphocytic leukemia: A major hallmark of the disease is the apoptotic resistance of CLL B cells, which seems to be mediated by increased levels of specific anti-apoptotic proteins such as B-cell lymphoma 2 (Bcl-2).